Skip to Content

BMS 250MG 6673 (Videx EC 250 mg)

Generic Name: didanosine

Pill with imprint BMS 250MG 6673 is White, Capsule-shape and has been identified as Videx EC 250 mg. It is supplied by Bristol-Myers Squibb.

Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 250MG 6673

Videx EC

Generic Name
didanosine
Imprint
BMS 250MG 6673
Strength
250 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
carboxymethylcellulose sodium, diethyl phthalate, methacrylic acid - methyl methacrylate copolymer (1:2), sodium hydroxide, sodium starch glycolate type A potato, magnesium silicate, gelatin, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00087-6673 Bristol-Myers Squibb Company
54569-5504 A-S Medication Solutions, LLC (repackager)
54868-5595 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.